Core Laboratories Inc. (FRA:HJ1)

Germany flag Germany · Delayed Price · Currency is EUR
11.40
-0.20 (-1.72%)
Last updated: Jun 3, 2026, 8:05 AM CET
Market Cap538.39M +8.2%
Revenue (ttm)455.10M +1.3%
Net Income25.18M +3.6%
EPS0.53 +4.5%
Shares Out n/a
PE Ratio21.38
Forward PE22.11
Dividend0.03 (0.29%)
Ex-Dividend DateMay 11, 2026
Volumen/a
Open11.40
Previous Close11.60
Day's Range11.40 - 11.40
52-Week Range8.30 - 16.80
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJul 22, 2026

About Core Laboratories

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize pr... [Read more]

Industry Oil and Gas Field Services, not elsewhere classified
Founded 1936
Employees 3,300
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol HJ1

Financial Performance

In 2025, Core Laboratories's revenue was $526.52 million, an increase of 0.51% compared to the previous year's $523.85 million. Earnings were $29.67 million, a decrease of -5.51%.

Financial numbers in USD Financial Statements

News

Core Laboratories Earnings Call Transcript: Q1 2026

Q1 2026 results were impacted by Middle East conflict, severe weather, and global supply disruptions, leading to lower revenue and margins. Despite these headwinds, the company maintained shareholder returns and expects modest sequential improvement, with long-term demand supported by global energy trends.

4 weeks ago - Transcripts

Core Laboratories Earnings release: Q1 2026

Core Laboratories released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Core Laboratories Quarterly report: Q1 2026

Core Laboratories has published its Q1 2026 quarterly earnings report on April 30, 2026.

4 weeks ago - Filings

Core Laboratories reports Q1 EPS 6c, consensus 11c

Reports Q1 revenue $121.8M, consensus $124.9M. Core’s CEO, Larry Bruno, stated, “First and foremost, our thoughts remain with our employees and their families across our Middle East operations during ...

4 weeks ago - TheFly

Core Laboratories sees Q2 EPS 6c-12c, two estimates 14c

Sees Q2 revenue $123M-$131M, two estimates $127.9M

4 weeks ago - TheFly

CORE LAB REPORTS FIRST QUARTER 2026 RESULTS

REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR GAAP LOSS PER SHARE OF $...

4 weeks ago - PRNewsWire

Core Laboratories Proxy statement: Proxy filing

Core Laboratories filed a proxy statement on March 31, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Core Laboratories Proxy statement: Proxy filing

Core Laboratories filed a proxy statement on March 31, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Core Laboratories sees Q1 EPS 5c-7c, two estimates 15c

Sees Q1 revenue $119M-$123M, two estimates $125.4M. The company states: “At this time, due to regional instability, including client-driven project delays, travel constraints, and supply-chain disrupt...

2 months ago - TheFly

Core Laboratories down 5% at $16.00 after Q1 pre-announcement

17:03 EDT Core Laboratories (CLB) down 5% at $16.00 after Q1 pre-announcement

2 months ago - TheFly

CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE

HOUSTON, March 23, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the Middle E...

2 months ago - PRNewsWire

Core Laboratories Earnings Call Transcript: Q4 2025

Fourth quarter revenue rose 3% sequentially and 7% year-over-year, with strong international demand offsetting US softness. Margins were pressured by tariffs, bad debt, and weather disruptions, but capital discipline and share buybacks continued. Guidance for Q1 2026 anticipates revenue of $124–$130 million and EPS of $0.11–$0.15.

4 months ago - Transcripts

Core Laboratories Earnings release: Q4 2025

Core Laboratories released its Q4 2025 earnings on February 5, 2026, summarizing the period's financial results.

4 months ago - Filings

Core Laboratories Annual report: Q4 2025

Core Laboratories has published its Q4 2025 annual report on February 5, 2026.

4 months ago - Filings

Core Laboratories Annual report: Q4 2025

Core Laboratories has published its Q4 2025 annual report on February 5, 2026.

4 months ago - Filings

Core Laboratories reports Q4 EPS 21c, consensus 19c

Reports Q4 revenue $138.3M, consensus $130.4M. Core’s CEO, Larry Bruno, stated, “Core Lab’s fourth quarter results were highlighted by sequential and year-over-year revenue growth that exceeded our pr...

4 months ago - TheFly

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000. Core's operating income was $15,...

4 months ago - PRNewsWire

CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.

5 months ago - PRNewsWire

Core Laboratories Earnings Call Transcript: Q3 2025

Q3 2025 saw over 3% sequential revenue growth, margin expansion, and strong international demand, with $5 million returned to shareholders via buybacks. Outlook remains constructive, with Q4 revenue projected at $132–$136 million and EPS of $0.18–$0.22.

7 months ago - Transcripts

Core Laboratories Earnings release: Q3 2025

Core Laboratories released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.

7 months ago - Filings

Core Laboratories Quarterly report: Q3 2025

Core Laboratories has published its Q3 2025 quarterly earnings report on October 23, 2025.

7 months ago - Filings

CORE LAB REPORTS THIRD QUARTER 2025 RESULTS

HOUSTON, Oct. 22, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2025 revenue of $134,500,000. Core's operating income was $20,...

7 months ago - PRNewsWire

CORE LABORATORIES ANNOUNCES STRATEGIC ACQUISITION OF BRAZIL-BASED SOLINTEC

HOUSTON , Sept. 30, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") announced today the acquisition of Brazil-based integrated geological services company, Solintec.

8 months ago - PRNewsWire

CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

HOUSTON, Sept. 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on October 23, 2025...

8 months ago - PRNewsWire

Core Laboratories Earnings Call Transcript: Q2 2025

Q2 2025 saw 5% sequential revenue growth, margin expansion, and strong free cash flow, with international demand and new technology deployments offsetting U.S. market softness. Guidance for Q3 projects stable revenue and continued focus on shareholder returns.

11 months ago - Transcripts